2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as S1P receptor agonists

Details for Australian Patent Application No. 2005299851 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Hale, Jeffrey John; Yan, Lin

Agent Spruson & Ferguson

Pub. Number AU-B-2005299851

PCT Pub. Number WO2006/047195

Priority 60/621,313 22.10.04 US

Filing date 18 October 2005

Wipo publication date 4 May 2006

Acceptance publication date 17 March 2011

International Classifications

C07D 271/00 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Event Publications

26 April 2007 PCT application entered the National Phase

  PCT publication WO2006/047195 Priority application(s): WO2006/047195

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

17 March 2011 Application Accepted

  Published as AU-B-2005299851

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005299852-CGRP receptor antagonists

2005299844-Cryogenic liquid storage structure